Letters to The Editor — April 30, 2025
Continue immunisation
The warning sounded by the World Health Organization, UNICEF and Gavi (the Vaccine Alliance), in the context of World Immunization Week, April 24-30, of 'increases in vaccine-preventable disease outbreaks threatening years of progress', is one that should not be ignored under any circumstances. Neglecting this could be catastrophic for the world.
All children and adults (especially women) should be immunised according to the latest national immunisation schedule sanctioned by the Ministry of Health & Family Welfare and ICMR. The Government of India must ensure that there is no slowing down of immunisation coverage.
Dr. Sunil Chopra,
Ludhiana, Punjab
Stray dog issue
As an octogenarian veterinarian, I have been keenly following the narratives on the stray dog problem.
Unfortunately, implementation of vaccination and sterilisation has not been as robust as it should have been, with concerns about inadequate outreach and sterilisation rates. A significant proportion of dogs remain reproductively active. As human health and life are important, this is an issue that has to be tackled through a more stringent and practical approach. Dog shelters can be set up in each corporation zone, roping in even corporates under Corporate Social Responsibility (CSR) initiatives. In many countries even pets are not allowed loose on a street.
Dr. T.N. Varadarajan,
Chennai
Shaji N. Karun
Shaji N. Karun, one among the pantheon of great film-makers, has become a glowing chapter in Kerala's rich film history. As a director and cinematographer, he excelled in both worlds. With his classic films such as Swaham, Piravi and Vanaprastham, he made an indelible mark in world cinema. And, while at the Kerala State Chalachithra Academy and Kerala State Film Development Corporation, he proved to be an institution builder.
Ayyasseri Raveendranath,
Aranmula, Kerala
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
3 hours ago
- NDTV
WHO Is Finalising A New Treaty To Prep For The Next Pandemic, But US Isn't Signing
On March 20, 2025, members of the World Health Organization adopted the world's first pandemic agreement, following three years of 'intensive negotiations launched by governments in response to the devastating impacts of the COVID-19 pandemic.' The U.S., however, did not participate, in part because of its intention to withdraw from the WHO. Global health experts are hailing the agreement as a historic moment. What does the agreement mean for the world, and how can it make everyone safer and more prepared for the next pandemic? The Conversation asked Nicole Hassoun, a professor at Binghamton University and executive director of Global Health Impact, to explain the pandemic accord, its prospects for advancing global health, and the significance of the U.S.'s absence from it. What will the pandemic agreement do? The accord will bolster pandemic preparation within individual countries and around the world. Countries signing onto the agreement are committing to improve their disease surveillance and grow their heath care workforces, strengthen their regulatory systems and invest in research and development. It encourages countries to strengthen their health regulations and infrastructure, improve communication with the public about pandemics and increase funding for preparation and response efforts. It also includes new mechanisms for producing and distributing vaccines and other essential countermeasures. Finally, it encourages countries to coordinate their responses and share information about infectious diseases and intellectual property so that vaccines and other essential countermeasures can be made available more quickly. The agreement will take effect once enough countries ratify it, which may take several years. Why isn't the US involved? The Biden administration was broadly supportive of a pandemic agreement and was an active participant in negotiations. Prior to Donald Trump's reelection, however, Republican governors had signed a letter opposing the treaty, echoing a conservative think tank's concerns about U.S. sovereignty. The U.S. withdrew from negotiations when President Trump signed an executive order to withdraw from the WHO on the day he was inaugurated for his second term. Why could the lack of US involvement be beneficial for the world? The lack of U.S. involvement likely resulted in a much more equitable treaty, and it is not clear that countries could have reached an agreement had the U.S. continued to object to key provisions. It was only once the U.S. withdrew from the negotiations that an agreement was reached. The U.S. and several other wealthy countries were concerned with protecting their pharmaceutical industry's profits and resisted efforts aimed at convincing pharmaceutical companies to share the knowledge, data and intellectual property needed for producing new vaccines and other essential countermeasures. Other negotiators sought greater access to vaccines and other treatments during a pandemic for poorer countries, which often rely on patented technologies from global pharmaceutical companies. While most people in wealthy countries had access to COVID-19 vaccines as early as 2021, many people in developing countries had to wait years for vaccines. How could the agreement broaden access for treatments? One of the contentious issues in the pandemic agreement has to do with how many vaccines manufacturers in each country must share in exchange for access to genetic sequences to emerging infectious diseases. Countries are still negotiating a system for sharing the genetic information on pathogens in return for access to vaccines themselves. It is important that researchers can get these sequences to make vaccines. And, of course, people need access to the vaccines once they are developed. Still, there are many more promising aspects of the agreement for which no further negotiations are necessary. For instance, the agreement will increase global vaccine supply by increasing manufacturing around the world. The agreement also specifies that countries and the WHO should work together to create a mechanism for fairly sharing the intellectual property, data and knowledge needed to produce vaccines and other essential health products. If financing for new innovation requires equitable access to the new technologies that are developed, many people in poor countries may get access to vaccines much more quickly in the next pandemic. The agreement also encourages individual countries to offer sufficient incentives for pharmaceutical companies to extend access to developing countries. If countries implement these changes, that will benefit people in rich countries as well as poor ones. A more equitable distribution of vaccines can contain the spread of disease, saving millions of lives. What more should be done, and does the US have a role to play? In my view, the best way to protect public health moving forward is for countries to sign on to the agreement and devote more resources to global health initiatives. This is particularly important given declining investment and participation in the WHO and the contraction of other international health initiatives, such as USAID. Without international coordination, it will become harder to catch and address problems early enough to prevent epidemics from becoming pandemics. It will also be imperative for member countries to provide funding to support the agreement's goals and secure the innovation and access to new technologies. This requires building the basic health infrastructure to ensure shots can get into people's arms.
The Hindu
5 hours ago
- The Hindu
SBI sets up four baby feeding centres in Bengaluru
As part of its Corporate Social Responsibility (CSR) initiative, the State Bank of India's Bengaluru Circle, in collaboration with the Child Help Foundation, has established four baby feeding centres across Bengaluru. The centres are located at Banashankari, R.V. Road, Benniganahalli Metro Stations, and the Indira Gandhi Institute of Child Health. These facilities provide clean, private spaces for nursing mothers — a vital resource for working women and daily commuters, said a release from SBI. Strategically positioned in busy transit hubs and a children's hospital, the centres aim to meet the pressing need for accessible breastfeeding spaces in public areas. Joohi Smitha Sinha, chief general manager of SBI Bengaluru Circle, inaugurated the Benniganahalli centre on Wednesday. Lakshman Singh, Chief General Manager of BMRCL, and Rajiv Menon from the Child Help Foundation were present.
The Hindu
5 hours ago
- The Hindu
Europe suffers its largest diphtheria outbreak in 70 years
The largest diphtheria outbreak to strike Western Europe in 70 years has been affecting vulnerable people such as migrants and the homeless since 2022, new research said Wednesday. Diphtheria is a highly contagious bacterial infection that can attack the respiratory tract and spread throughout the body, causing a sore throat, fever and other symptoms. For unvaccinated people, it can be fatal in around 30 percent of cases, and is deadlier for children, according to the World Health Organization. In 2022, there was an unusual surge in the bacteria that causes diphtheria -- Corynebacterium diphtheriae -- in several European countries, particularly among recently arrived migrants, according to a study in the New England Journal of Medicine. That year 362 cases were recorded by the European Centre for Disease Prevention and Control. Contact tracing and screening helped tamp down the outbreak, but rare infections have continued to be recorded, the researchers said. A total of 536 cases, including three deaths, have been recorded across Europe since the start of 2022. Patient samples from 10 countries showed that 98 percent of the cases were in males with an average age of 18. Almost all had recently migrated. "The outbreak, which mainly affected migrants from Afghanistan and Syria, was not the result of people being infected in their countries of origin, but during their migration journeys or in their places of accommodation in European countries," said a joint statement from France's public health agency and the Pasteur Institute. The genetic similarities between the strains seen in people from different countries suggests that there was a "recent point of contact, outside the country of origin" at the source of the outbreak, the statement added. The exact areas affected by the outbreak remains unclear. But a genetic link between the 2022 strain and the one detected in Germany this year indicates that "the bacteria continues to circulate quietly in Western Europe," the statement said. Vaccination is very effective at fending off diphtheria, and the researchers emphasised the importance of immunisation programmes for the general public. They also called for European nations to do more to ensure their most vulnerable people avoid contracting the disease. That included raising awareness of the symptoms among doctors and those in contact with migrants and the homeless, as well as increasing access to vaccines and antibiotic drugs.
